Reporting on invasive lobular breast cancer in clinical trials: a systematic review

Reporting on invasive lobular breast cancer in clinical trials: a systematic review

Abstract Invasive lobular breast cancer (ILC) differs from invasive breast cancer of no special type in many ways. Evidence on treatment efficacy for ILC is, however, lacking. We studied the degree of documentation and representation of ILC in phase III/IV clinical trials for novel breast cancer tre...

Full description

Bibliographic Details
Main Authors: Karen Van Baelen, Josephine Van Cauwenberge, Marion Maetens, Gabriela Beck, Ann Camden, Megan-Claire Chase, Valerie Fraser, Siobhan Freeney, Laurie Hutcheson, Julia K. Levine, Tone Lien, Rian Terveer, Claire Turner, Elzbieta Senkus, Rachel C. Jankowitz, Vincent Vandecaveye, Giuseppe Floris, Patrick Neven, Hans Wildiers, Elinor Sawyer, Anne Vincent-Salomon, Patrick W. B. Derksen, Christine Desmedt
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-024-00627-5

Internet

https://doi.org/10.1038/s41523-024-00627-5

Similar Items